Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Evidence- |
RCV000495721 | SCV000578274 | likely benign | Breast-ovarian cancer, familial, susceptibility to, 1 | 2017-06-29 | reviewed by expert panel | curation | Synonymous substitution variant, with low bioinformatic likelihood to result in a splicing aberration (Splicing prior probability 0.02; http://priors.hci.utah.edu/PRIORS/). |
Eurofins Ntd Llc |
RCV000174361 | SCV000225647 | uncertain significance | not provided | 2015-04-20 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001088804 | SCV000560198 | likely benign | Hereditary breast ovarian cancer syndrome | 2023-10-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000573684 | SCV000665835 | likely benign | Hereditary cancer-predisposing syndrome | 2016-04-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000174361 | SCV004219397 | likely benign | not provided | 2023-04-22 | criteria provided, single submitter | clinical testing |